Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides. 2002

Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
Biochemisches Institut der Universitatsklinik Giessen, Friedrichstrasse 24, D-35249, Giessen, Germany.

We have described 5-(4-propoxycinnamoylamino)-2-(4-tolylacetylamino)benzophenone 6e as a novel lead for anti-malarial agents. Anti-malarial activity of these 5-(4-propoxycinnamoylamino)benzophenones proved to be quite sensitive against variations of the acyl substituent at the 2-amino group. Best activity was obtained with phenylacetic acid moieties carrying small substituents in the para-position. From the para-substituents evaluated, the trifluoromethyl group yielded the most active compound (6j) in this series (IC50=120 nM). Deviations from the phenylacetic acid substructure, shifting the substituent into the ortho-position or bulkier para-substituents resulted in a significant reduction in anti-malarial activity.

UI MeSH Term Description Entries
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
October 2002, Bioorganic & medicinal chemistry letters,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
February 2002, Bioorganic & medicinal chemistry,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
July 2003, Bioorganic & medicinal chemistry letters,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
February 2001, Bioorganic & medicinal chemistry letters,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
April 2003, Bioorganic & medicinal chemistry,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
September 2004, Bioorganic & medicinal chemistry,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
July 2005, Archiv der Pharmazie,
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
May 2015, Molecules (Basel, Switzerland),
Jochen Wiesner, and Katja Kettler, and Hassan Jomaa, and Martin Schlitzer
March 1989, Journal of medicinal chemistry,
Copied contents to your clipboard!